期刊文献+

GRIM-19不同表达水平对前列腺癌细胞多西他赛化疗耐药性的影响

Effect of different expression levels of GRIM-19 on the resistance of prostate cancer cells to docetaxel chemotherapy
下载PDF
导出
摘要 目的:探讨GRIM-19对多西他赛治疗前列腺癌(PCa)细胞的化疗耐药性的影响。方法:利用siRNA技术干扰PCa细胞的基因表达,建立GRIM-19过表达/敲除的PCa细胞模型,通过qPCR、Western印迹和流式细胞术等方法,探索GRIM-19不同表达水平对多西他赛诱导PCa细胞死亡的影响情况,揭示GRIM-19在PCa细胞化疗耐药性中的价值。结果:实验显示,GRIM-19在PCa组织和细胞中表达下调;GRIM-19敲除后,siGRIM-19在PC-3和LNCaP细胞中的表达明显降低,PC-3和LNCaP细胞接受不同剂量的多西他赛处理时,与对照组相比,GRIM-19的敲除降低了细胞死亡率;实验发现,GRIM-19过表达转染后,GRIM-19 mRNA和蛋白的表达明显增加,过表达的GRIM-19以剂量依赖性的方式促进多西他赛诱导的PC-3和LNCaP细胞死亡;用流式细胞术分析多西他赛诱导PC-3和PC-3-R细胞在不同时间和不同浓度的凋亡情况,结果显示PC-3-R细胞比PC-3细胞凋亡减少。结论:GRIM-19具有明显的促进细胞凋亡作用,是PCa抑癌基因;GRIM-19过表达促进了多西他赛诱导的PCa细胞死亡,提高了化疗敏感性。 Objective:To investigate the effect of GRIM-19 on the resistance of carcinoma cells to the chemotherapeutic agent docetaxel in the treatment of PCa.Methods:Using siRNA technology to interfere with the gene expression in PCa cells,we established a model of GRIM-19 overexpression/knockdown in PCa cells.We investigated the effect of different expression levels of GRIM-19 on docetaxel-induced death of the PCa cells by qPCR,Western blot and flow cytometry,and assessed the value of GRIM-19 in reducing the chemotherapy-resistance of PCa cells.Results:GRIM-19 was down-regulated in PCa tissues and cells.Knockout of GRIM-19 significantly decreased the expression of siGRIM19 in the PC-3 and LNCaP cells,and reduced their death rate when treated with docetaxel compared with the control group.The expressions of GRIM-19 mRNA and protein were remarkably upregulated after transfection with GRIM-19,and the overexpressed GRIM-19 promoted the death of the PC-3 and LNCaP cells treated with docetaxel in a dose-dependent manner.Flow cytometry analysis showed a lower apoptosis rate of PC-3-R cells than that of PC-3 cells at different time points of docetaxel-induction at different doses.Conclusion:GRIM-19 is a PCa suppressor gene with a significant facilitating effect on the apoptosis of PCa cells,and the overexpression of GRIM-19 promotes docetaxel-induced PCa cell death and improves the sensitivity of chemotherapy.
作者 林海利 贺永新 林天旗 沈在雄 罗流涛 黄思兴 黄倚 周宇 阮敏毅 LIN Hai-li;HE Yong-xin;LIN Tian-qi;SHEN Zai-xiong;LUO Liu-tao;HUANG Si-xing;HUANG Yi;ZHOU Yu;RUAN Min-yi(Department of Urology,Zhangzhou Hospital Affiliated to Fujian Medical University,Zhangzhou,Fujian 363000,China;Department of Medical Affairs,Zhangzhou Hospital Affiliated to Fujian Medical University,Zhangzhou,Fujian 363000,China)
出处 《中华男科学杂志》 CAS CSCD 2024年第10期884-888,共5页 National Journal of Andrology
基金 福建省自然科学基金(2020J011298)。
关键词 前列腺癌 GRIM-19 多西他赛 耐药性 prostate cancer GRIM19 docetaxel drug resistance Received:December 30,2023 accepted:August 20,2024
  • 相关文献

参考文献2

二级参考文献6

  • 1赫杰,赵平,陈万青.2011中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:2-5,26 -37,74 -75.
  • 2Segi M. Cancer mortality for selected sites in 24 countries(1950-57 ) [ M ]. Japan : Department of Public Health,Tohoku Univer-sity of Medicine, 1960.
  • 3FerlayJ, Shin HR, Bray F, et al. Estimates of worldwide burdenof cancer in 2008 : GLOBOCAN 2008 [ J]. Int J Cancer, 2010,127(12) : 2893 -2917.
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin’2011,61(2) :69 -90.
  • 5Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J].CA Cancer J Clin,2012,62( 1) :10 - 29.
  • 6陈波,曹德宏,郭建兵,柳良仁,魏强.去势抵抗性前列腺癌中雄激素生物合成的研究进展[J].中华男科学杂志,2019,25(3):265-271. 被引量:8

共引文献779

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部